Literature DB >> 33441606

Survivin and caspases serum protein levels and survivin variants mRNA expression in sepsis.

Marianna Miliaraki1,2, Panagiotis Briassoulis1,2, Stavroula Ilia1,2, Aikaterini Polonifi3, Marina Mantzourani3, Efrossini Briassouli3, Konstantinos Vardas4, Serafim Nanas4, Aikaterini Pistiki5, Maria Theodorakopoulou6, Theonymfi Tavladaki1, Anna Maria Spanaki1, Eumorfia Kondili7, Helen Dimitriou8, Sotirios Tsiodras5, Dimitrios Georgopoulos7, Apostolos Armaganidis6, George Daikos3, George Briassoulis9,10.   

Abstract

Sepsis is a dysregulated host response to infection related to devastating outcomes. Recently, interest has been shifted towards apoptotic and antiapoptotic pathobiology. Apoptosis is executed through the activation of caspases regulated by a number of antiapoptotic proteins, such as survivin. The survivin and caspases' responses to sepsis have not yet been elucidated. This is a multicenter prospective observational study concerning patients with sepsis (n = 107) compared to patients with traumatic systemic inflammatory response syndrome (SIRS) (n = 75) and to healthy controls (n = 89). The expression of survivin was quantified through real-time quantitative polymerase chain reaction for the different survivin splice variants (wild type-WT, ΔEx3, 2B, 3B) in peripheral blood leukocytes. The apoptotic or antiapoptotic tendency was specified by measuring survivin-WT, caspase-3, and -9 serum protein concentrations through enzyme-linked immunosorbent assay. The survivin-WT, -2B, -ΔΕx3 mRNA, survivin protein, and caspases showed an escalated increase in SIRS and sepsis, whereas survivin-3B was repressed in sepsis (p < 0.05). Survivin correlated with IL-8 and caspase-9 (p < 0.01). For discriminating sepsis, caspase-9 achieved the best receiver operating characteristic curve (AUROC) of 0.95. In predicting mortality, caspase-9 and survivin protein achieved an AUROC of 0.70. In conclusion, specific apoptotic and antiapoptotic pathways might represent attractive targets for future research in sepsis.

Entities:  

Year:  2021        PMID: 33441606      PMCID: PMC7806640          DOI: 10.1038/s41598-020-78208-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  67 in total

1.  HBXIP functions as a cofactor of survivin in apoptosis suppression.

Authors:  Hiroyuki Marusawa; Shu-Ichi Matsuzawa; Kate Welsh; Hua Zou; Robert Armstrong; Ingo Tamm; John C Reed
Journal:  EMBO J       Date:  2003-06-02       Impact factor: 11.598

2.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

3.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

Review 4.  Survivin at a glance.

Authors:  Sally P Wheatley; Dario C Altieri
Journal:  J Cell Sci       Date:  2019-04-04       Impact factor: 5.285

5.  Apoptosis in murine norovirus-infected RAW264.7 cells is associated with downregulation of survivin.

Authors:  Karin Bok; Victor G Prikhodko; Kim Y Green; Stanislav V Sosnovtsev
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.

Authors:  Solmaz Moniri Javadhesari; Javad Gharechahi; Mohammad Ali Hosseinpour Feizi; Vahid Montazeri; Monireh Halimi
Journal:  Genet Test Mol Biomarkers       Date:  2013-01-31

7.  The survivin isoform survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.

Authors:  Shirley K Knauer; Carolin Bier; Peter Schlag; Johannes Fritzmann; Wolfgang Dietmaier; Franz Rödel; Ludger Klein-Hitpass; Adoriàn F Kovács; Claudia Döring; Martin-Leo Hansmann; Wolf-Karsten Hofmann; Martin Kunkel; Christoph Brochhausen; Knut Engels; Burkhard M Lippert; Wolf Mann; Roland H Stauber
Journal:  Cell Cycle       Date:  2007-04-15       Impact factor: 4.534

8.  Farnesyltransferase inhibitor improved survival following endotoxin challenge in mice.

Authors:  Shohei Shinozaki; Yoko Inoue; Wen Yang; Makiko Fukaya; Edward A Carter; Yong-Ming Yu; Young Ming-Yu; Alan Fischman; Ronald Tompkins; Masao Kaneki
Journal:  Biochem Biophys Res Commun       Date:  2009-12-23       Impact factor: 3.575

9.  Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils.

Authors:  Frank Altznauer; Sibylla Martinelli; Shida Yousefi; Christine Thürig; Inès Schmid; Edward M Conway; Martin H Schöni; Peter Vogt; Christoph Mueller; Martin F Fey; Uwe Zangemeister-Wittke; Hans-Uwe Simon
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

View more
  3 in total

Review 1.  Caspase-9: A Multimodal Therapeutic Target With Diverse Cellular Expression in Human Disease.

Authors:  Maria I Avrutsky; Carol M Troy
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.988

2.  Oxidant/Antioxidant Status Is Impaired in Sepsis and Is Related to Anti-Apoptotic, Inflammatory, and Innate Immunity Alterations.

Authors:  Marianna Miliaraki; Panagiotis Briassoulis; Stavroula Ilia; Kalliopi Michalakakou; Theodoros Karakonstantakis; Aikaterini Polonifi; Kalliopi Bastaki; Efrossini Briassouli; Konstantinos Vardas; Aikaterini Pistiki; Maria Theodorakopoulou; Theonymfi Tavladaki; Anna-Maria Spanaki; Eumorfia Kondili; Helen Dimitriou; Maria Venihaki; Sotirios Tsiodras; Dimitrios Georgopoulos; Marina Mantzourani; Serafeim Nanas; Apostolos Armaganidis; George L Daikos; Ioannis Papassotiriou; George Briassoulis
Journal:  Antioxidants (Basel)       Date:  2022-01-25

3.  Necroptosis-Mediated eCIRP Release in Sepsis.

Authors:  Bridgette Reilly; Chuyi Tan; Atsushi Murao; Colleen Nofi; Alok Jha; Monowar Aziz; Ping Wang
Journal:  J Inflamm Res       Date:  2022-07-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.